Skip to main content

Is diamedica.com a Scam? Security Check Results - DiaMedica Therapeutics, Inc.

diamedica.com favicon

Is diamedica.com Safe? Security Analysis for DiaMedica Therapeutics, Inc.

http://diamedica.com

Check if diamedica.com is a scam or legitimate. Free security scan and reviews.

HealthcareUnited Statessmall
Google Analytics (GA4)FontAwesomeGoogle FontsjQuery (implied by dataTables usage)Video HTML5+1 more
Analyzed 6/25/2025Completed 1:33:29 AM
69
Security Score
MEDIUM RISK
Exclusive insights unlocked

Unlock the complete security report for diamedica.com

Get full access to AI recommendations, compliance evidence, vulnerability remediation steps, and downloadable PDF reports. Upgrade once for lifetime access to this scan.

Full Report Access

All modules, AI insights, PDF download

39.90 €one-time • Incl. 21% VAT

Marketing Intelligence

Contact emails, phone numbers & warm leads

49.90 €one-time • Incl. 21% VAT

How it works

  1. Enter your email to receive the unlocked report.
  2. Complete the secure EveryPay checkout (cards & local methods supported).
  3. You’ll receive an email with your unique unlock code and the PDF export.

Already purchased?

Order summary

Domaindiamedica.com
Access tierFull report or marketing add-on

Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.

VisaMastercardApple PayGoogle Pay

Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.

SEQ SIA

Lastadijas 12 k-3, Riga, Latvia, LV-1050

Reg. No. 40203410806 • VAT LV40203410806

Support: guard@offseq.com+371 2256 5353

AI Summary

DiaMedica Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on developing innovative synthetic protein therapies targeting serious vascular diseases such as preeclampsia and acute ischemic stroke.… Unlock the full Guard report to read the complete analysis.

Detected Technologies

Google Analytics (GA4)FontAwesomeGoogle FontsjQuery (implied by dataTables usage)Video HTML5Cloudfront CDN
Continuous monitoring

Keep diamedica.com under constant watch

Guard tracks your live infrastructure daily: certificate expiry, DNS & mail authentication drift, uptime changes, subdomain inventory, and unexpected tracker or content shifts. A full timeline captures every diff so you can prove remediation and spot regressions instantly.

Security drift alerts

Risk score drops, new high-severity issues, and header hardening gaps

Compliance watch

GDPR / NIS2 posture changes with governance evidence snapshots

Infrastructure surface

Unexpected open services, SSL expiry, DNS & email authentication changes

Content & tracker intelligence

Marketing tech shifts, analytics drift, and AI recommendation updates

25 €
per month · billed securely via EveryPay

Cancel anytime. Alerts sent to the contacts you choose. Unlock the full report to view historical timelines and alerts.

Unlock the full Guard report to view the monitoring timeline, JSON diffs, and alert history for diamedica.com.

Security Headers

No critical findings yet

100/100

GDPR Compliance

4 findings

53/100

NIS2 Compliance

8 findings

17/100

Email Security

4 findings

70/100

🧠AI Business Intelligence

Technology stack, business insights, and market analysis powered by AI.

Snapshot shown below. Unlock the full AI report for complete market insights, audience profiling, and step-by-step recommendations.

Business Intelligence

Market & Strategic Analysis

The company operates in the healthcare sector, specifically biopharmaceuticals, targeting unmet medical needs in vascular diseases. Their business model centers on drug development and clinical trials, with a focus on synthetic proteins. Market positioning is that of a clinical stage innovator with a clear focus on preeclampsia and stroke. The presence on Nasdaq and inclusion in Russell indexes indicate some market recognition. The website content targets investors, healthcare professionals, and patients, emphasizing clinical data and event information. Growth indicators include ongoing clinical trials and recent investor events. The company appears to have a focused partnership ecosystem but no explicit partner domains were identified. Strategic observations suggest the company is in a growth and development phase, with opportunities to improve digital trust and compliance.

Extracted Contact Information

Marketing Intelligence Data

Security Posture Analysis

Comprehensive Security Assessment

The website demonstrates a good security baseline with HTTPS enabled and no visible exposure of sensitive data. Use of nonce attributes in scripts indicates some mitigation against script injection. However, the absence of key security headers such as Content-Security-Policy, X-Frame-Options, and X-Content-Type-Options reduces defense-in-depth. No vulnerability disclosures or incident response contacts are published, limiting transparency and readiness perception. Privacy compliance is lacking, with no cookie consent or privacy policy detected, which may expose the company to regulatory risk. The missing WHOIS data is a significant concern for domain legitimacy and trust. Overall, the security posture is moderate but requires improvements in policy transparency and header implementation.

Strategic Recommendations

Priority Actions for Security Improvement

1

Upgrade to the full Guard report to access tailored remediation steps.

Observations

AI-powered comprehensive website and business analysis.

A preview of your strategic observations is visible. Upgrade to unlock the full competitive positioning, trust signals, and branding checklist.

AI-Enhanced Website Analysis

Business Insights

Company:

DiaMedica Therapeutics, Inc.

Description:

DiaMedica Therapeutics is a biopharmaceutical company that specializes in creating synthetic proteins to treat a variety of conditions. DiaMedica Therapeutics Inc. is a clinical stage biopharmaceutical company committed to improving the lives of people suffering from preeclampsia and acute ischemic stroke. DiaMedica’s lead candidate, DM199, is the first pharmaceutically active recombinant (synthetic) form of the KLK1 protein, an established therapeutic modality in Asia for the treatment of acute ischemic stroke, preeclampsia and other vascular diseases.

Key Services:
Development of synthetic proteinsClinical trials for preeclampsia and acute ischemic stroke treatments
Content Quality:

good

Branding:

consistent

Technical Stack

Technologies:
Google Analytics (GA4)FontAwesomeGoogle FontsjQuery (implied by dataTables usage)Video HTML5Cloudfront CDN
Performance:

moderate

Mobile:

good

Accessibility:

basic

SEO:

good

Security Assessment

Security Score:
85/100
Best Practices:
  • HTTPS enabled
  • No visible exposed sensitive data in HTML
  • Use of nonce attribute in inline scripts

Analytics & Tracking

Services:
Google Analytics (GA4)
Tracking Level:moderate
Privacy Compliance:poor

Advertising & Marketing

Transparency Level:basic

Website Quality Assessment

Design Quality:good
User Experience:good
Content Relevance:good
Navigation Clarity:good
Professionalism:good
Trustworthiness:high

Key Observations

1

Website is fully accessible with rich content and multimedia

🛡️Security Headers

HTTP security headers analysis and recommendations.

Some header findings are shown. Unlock to see the full checklist, impacted endpoints, and remediation guidance.

Security Headers

HTTP security headers analysis

100/100
Score
No issues found

👤GDPR Compliance

Privacy and data protection assessment under GDPR regulations.

Preview of GDPR checkpoints is visible. Unlock to reveal full evidence, policy excerpts, and DPIA guidance.

GDPR Compliance

Privacy and data protection assessment

53/100
Score

No Cookie Policy found

HIGH

GDPR requires clear information about cookie usage Unlock the full report to read the complete fix.

No Cookie Consent Banner found

HIGH

GDPR requires explicit consent for non-essential cookies Unlock the full report to read the complete fix.

No Data Protection Officer mentioned

LOW

Large organizations may need to designate a DPO under GDPR Unlock the full report to read the complete fix.

Privacy policy may not be GDPR compliant

MEDIUM

Privacy policy lacks explicit GDPR compliance elements Unlock the full report to read the complete fix.

GDPR Compliance Analysis

Privacy Policy85% confidence
Cookie Policy0% confidence
Contact Information Found90% confidence
phone

🛡️NIS2 Compliance

Network & Information Security Directive compliance assessment.

You can see headline NIS2 checks. Upgrade to access the full control mapping, severity breakdown, and remediation plan.

NIS2 Compliance

Network & Information Security Directive

17/100
Score

No information security framework found

HIGH

NIS2 requires documented cybersecurity and information security measures Unlock the full report to read the complete fix.

No vulnerability disclosure policy

MEDIUM

NIS2 encourages coordinated vulnerability disclosure Unlock the full report to read the complete fix.

No security policy documentation found

HIGH

NIS2 requires documented cybersecurity governance and risk management Unlock the full report to read the complete fix.

No incident response procedures found

HIGH

NIS2 requires documented incident response and business continuity plans Unlock the full report to read the complete fix.

No business continuity planning found

MEDIUM

NIS2 emphasizes operational resilience and business continuity Unlock the full report to read the complete fix.

No security contact information

HIGH

NIS2 requires clear incident reporting channels Unlock the full report to read the complete fix.

No vulnerability reporting mechanism

MEDIUM

Clear vulnerability reporting supports coordinated disclosure Unlock the full report to read the complete fix.

No NIS2 reference found

LOW

Consider explicitly mentioning NIS2 compliance efforts Unlock the full report to read the complete fix.

📧Email Security

SPF, DKIM, and DMARC validation and email security assessment.

Quick view of email authentication checks is provided. Unlock to uncover full DNS evidence, record diffs, and fix scripts.

Email Security

SPF, DKIM, and DMARC validation

70/100
Score

No DKIM record found

MEDIUM

DKIM adds cryptographic signatures to emails Unlock the full report to read the complete fix.

No BIMI Record

LOW

BIMI displays brand logos in email clients Unlock the full report to read the complete fix.

No MTA-STS Policy

MEDIUM

MTA-STS enforces TLS for email delivery Unlock the full report to read the complete fix.

No TLS-RPT Record

LOW

TLS-RPT provides reporting for email TLS issues Unlock the full report to read the complete fix.

SPF
Sender Policy Framework
DKIM
DomainKeys Identified Mail
DMARC
Domain-based Message Authentication
MX Records
Mail Exchange Records
BIMI
Brand Indicators
MTA-STS
Mail Transfer Agent Security
TLS-RPT
TLS Reporting
DNSSEC
DNS Security
SPF Details
Record:
v=spf1 include:_spf.prod.hydra.sophos.com ~all
DNS Lookups:1/10
Policy:~all

🏆SSL/TLS Security

Certificate validity and encryption analysis.

This is a teaser of the TLS audit. Unlock to view certificate chains, cipher support tables, and remediation steps.

SSL/TLS Security

Certificate validity and encryption analysis

62/100
Score

Weak Protocols Supported

HIGH

Server supports weak protocols: TLSv1.1 Unlock the full report to read the complete fix.

OCSP Stapling Not Enabled

LOW

OCSP stapling improves performance and privacy Unlock the full report to read the complete fix.

Certificate Transparency Not Implemented

LOW

Certificate is not logged in Certificate Transparency logs Unlock the full report to read the complete fix.

SSL Certificate Expires Within 90 Days

MEDIUM

SSL certificate expires in 82 days Unlock the full report to read the complete fix.

Mixed Content Detected

MEDIUM

4 resources loaded over insecure HTTP Unlock the full report to read the complete fix.

Partial SSL/TLS Assessment

LOW

Completed 3 of 4 security checks due to time constraints Unlock the full report to read the complete fix.

Protocol Support

TLSv1.3TLSv1.2TLSv1.1

OCSP Status

OCSP Stapling Disabled

📊DNS Health

DNS configuration and security assessment.

Unlock the full DNS posture audit to reveal misconfigurations, zone records, and actionable fixes.

DNS Health

DNS configuration and security assessment

75/100
Score

DNSSEC Not Enabled

MEDIUM

DNSSEC is not configured for this domain Unlock the full report to read the complete fix.

CAA Records Not Configured

LOW

Certificate Authority Authorization (CAA) records not found Unlock the full report to read the complete fix.

No DMARC Record

MEDIUM

DMARC policy not configured Unlock the full report to read the complete fix.

DNS Records

A Records:174.129.30.187
Name Servers:
ns53.worldnic.comDNS only
ns54.worldnic.comDNS only
MX Records:
10: mx-02-us-west-2.prod.hydra.sophos.com
10: mx-01-us-west-2.prod.hydra.sophos.com
SOA:Serial: 123112120, TTL: 3600s

DNSSEC Status

DNSSEC Not Enabled

DNS Performance

Resolution Time:191ms

SPF Analysis

SPF Record:
v=spf1 include:_spf.prod.hydra.sophos.com ~all

Network Security

Port scanning and network exposure analysis.

See a glimpse of exposed services. Unlock to access full port inventories, CVE lookups, and mitigation priorities.

Network Security

Port scanning and network exposure analysis

100/100
Score

Good Network Security Posture

LOW

No unnecessary services detected on common risky ports Unlock the full report to read the complete fix.

🔧Technical Analysis

Detailed technical findings and analysis from AI assessment.

Unlock to view the complete technical breakdown, stack fingerprinting, and hardening checklist.

Technical Analysis

Comprehensive security assessment findings

Additional Findings

Unlock the full Guard report to review the complete technical breakdown and AI recommendations.
⭐ Verified Community Reviews

What others say about diamedica.com

Share your experience to help others make informed decisions. We verify every review by email and publish it once our moderation team approves it.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

out of 5

0 reviews published

Loading reviews…

How did we do?

Your feedback directly shapes our roadmap. Rate the quality of this report, leave an optional comment, and let us know if you want our security specialists to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.

Analyze Another Website